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Available online 29 June 2012Preoperative biopsies or imbedded cytological cells will become more and more a primary source of tissue for
molecular diagnostic analyses as a result of novel neo-adjuvant treatment regimens for several cancer types.
Furthermore there is a growing need to examine metastatic cancer tissue. Hence, nucleic acids need to be re-
liably isolated and analyzed from small amounts of formalin-ﬁxed and parafﬁn-embedded (FFPE) tissue. The
limited numbers of (tumor) cells in these samples make high quality and sensitive DNA isolation challenging.
Also demands for faster turnaround times are growing. Therefore, we evaluated a fully automated DNA/RNA
isolation system and compared this with a manual, classical routine molecular pathology method. We com-
pared the quality of the isolates from both tissue cores and micro-dissection for detection of hotspot muta-
tions in KRAS, BRAF applying hydrolysis probe assays. In addition we determined whether the automated
method decreases the hands-on-time and turnaround times in routine molecular pathology workﬂow.
In conclusion, the automated method delivers high quality DNA from both small FFPE tissue cores and
micro-dissected tissue material. In comparison to classical methods, less than 50% of starting tissue was suf-
ﬁcient as input for micro-dissection. Turnaround times decreased signiﬁcantly and 50% less hands-on time
was needed.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Increasing numbers of cancer biomarkers have been implemented
in molecular tumor diagnostics worldwide (de Silva and Reid, 2003;
Gazdar, 2009; Heinemann et al., 2009; Wellbrock et al., 2004). Muta-
tions in KRAS predict for resistance to monoclonal antibody therapy in
colon cancer patients (Karapetis, 2008). In BRAF, the V600E and the
rarer V600K variant are found in the majority of cutaneous melano-
ma, making the patients eligible for treatment with vemurafenib
(PLX4032). (Vidwans et al., 2011) A subset of non‐small cell lung can-
cers may harbor activating mutations in the EGFR kinase domain and
might thereby respond to certain tyrosine kinase inhibitors (Gazdar,
2009). Thus, based on these test results for KRAS, BRAF and EGFR, pa-
tients may be selected for guided treatment. Furthermore, a delay in
the start of treatment of a cancer patient might inﬂuence the patient's
life expectation (e.g., for the treatment of lung cancer with tyrosine
kinase inhibitors). In addition, the amount of cancer material that is
available for testing is decreasing as a result of the introduction of
neo-adjuvant treatment protocols and the growing need to examine
metastatic cancer tissue. Less invasive sampling procedures (van
Eijk et al., 2011) may lead to little amounts of material.-ND license.The starting point in biomarker testing in pathological specimen is
the efﬁcient isolation of nucleic acids. These can be isolated from
formalin-ﬁxed, parafﬁn-embedded (FFPE) tissue from whole tumor
sections, micro-dissectedmaterial, tissue cores or imbedded cytological
material (Boldrini et al., 2007; Hunt, 2008). In FFPE tissue DNA degra-
dation has already taken place resulting in a negative contribution to
the quantity and quality of the DNA. (Ferrer et al., 2007; Klopﬂeisch
et al., 2011) Several manual and semi-automated methods have been
described for DNA extraction from FFPE tissue (Muñoz-Cadavid et al.,
2010; Torrente et al., 2010). DNA quality and quantity obtained with
these different techniques are variable. This variability is primarily
due to the quality of the material that has been used and not because
of the quality of the isolation technique (Gilbert et al., 2007). Neverthe-
less, all techniques described thus far require many hours of hands-on
time and include operator-to-operator variation that might contribute
to less reproducible and robust results (Bonin et al., 2010). Part of the
hands-on time is due to the manual micro-dissection and lysis of the
tumor tissue. However, deparafﬁnization is a crucial, time consuming
step that can impact the quality and quantity of the extraction
(Steinau et al., 2011). Moreover, this process often includes the use of
toxic reagents such as xylene (Goelz et al., 1985). Additionally, in
many cases, and speciﬁcally in micro-dissection, the ﬁnal DNA yield is
low and of reduced quality, thereby requiring additional steps such as
whole genome ampliﬁcation or other pre-ampliﬁcation steps in order
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al., 2010; Lim et al., 2009; van Eijk et al., 2010). Therefore, there is an
increasing demand for fully automated, optimized and time-saving
methods for the high quality DNA extraction from limited amounts of
material.
Here we describe DNA extraction using a fully automated DNA/
RNA extraction system which can process 48 tissue samples in 3 h
and 15 min using silica-coated magnetic nanoparticles. The process
integrates both lysis and deparafﬁnization by hydrophobic adsorption
instead of ofﬂine xylene based deparafﬁnization (Bohmann et al.,
2009; Hennig et al., 2010). We investigated if the quality of the isolat-
ed DNA from tissue cores and micro-dissected tissue obtained with
this newly described method compares to our classical method. We
also evaluated if the method decreases the turnover (turnaround)
time for our most common molecular assays.
We determined that the fully automated method delivers high
quality DNA from small tissue cores and micro-dissected material as
compared to our classical method. For micro-dissection we found
that only 20%–50% of starting material was needed for the fully auto-
mated method when compared to the classical method. When the
DNA is used in hydrolysis probe assays we achieved 24 h faster
turnover (turnaround) time with 50% less hands-on time being
required.
Material and methods
Ethics statement
All samples used in this study were handled according to the med-
ical ethical guidelines described in the Code Proper Secondary Use of
Human Tissue established by the Dutch Federation of Medical Sci-
ences (www.federa.org, accessed October 27, 2010). According to
these guidelines, the speciﬁc need for the ethics committee's approval
was not necessary for this study because all human material used in
this study has been anonymized.
Test material
This study included formalin-ﬁxed, parafﬁn-embedded tissue sam-
ples obtained from micro-dissected tissue from slides (10 μm) and
tissue cores (0.3 mm diameter and variable length) of different tissue
types (Supplementary Table 1–4). Hematoxylin-eosin staining was
performed on tissue sections to visualize presence of tumor cells.
These were used to guide micro-dissection on hematoxylin-stained
duplicate slides and to determine the area of the tissue cores.
DNA extraction
The classical method
Classical DNA extraction from FFPE material was performed
according to the method described by de Jong (De Jong et al., 2004).
In brief, the FFPE sections on slides or tissue cores were deparafﬁnized
by two xylene and ethanol washing steps (process includes centrifuga-
tion and incubation steps as well). The sections and cores were collect-
ed in various amounts of PK1 buffer depending on the amount of
material and then incubated overnight at 56 °C in the presence of pro-
teinase K and Chelex beads. If the volume of the PK1 buffer was under
15 μl no Chelex beads were added. The following day the samples were
further incubated at 100 °C for 10 min, centrifuged and then the super-
natant was transferred to a clean tube.
The fully automated method
The fully automated DNA extraction from FFPE tissue (Tissue
Preparation System with VERSANT Tissue Preparation Reagents,
Siemens Healthcare Diagnostics, Tarrytown, NY) has been described
previously, (Bohmann et al., 2009; Hennig et al., 2010) In this methodmicro-dissected tissue or tissue cores were directly transferred into
1.5 ml tubes (Sarstedt, Nümbrecht, Germany) and subjected to auto-
mated total nucleic acid extraction. Samples were heat lysed in 150 μl
FFPE buffer at 80 °C for 30 min with shaking. After cooling, enzymatic
lysis was carried out at 65 °C for 30 min with proteinase K. Any resid-
ual tissue debris was then removed by the nonspeciﬁc binding to
silica-coated iron oxide beads followed by subsequent magnetic sep-
aration. Deparafﬁnized and clariﬁed lysates were transferred to new
tubes and nucleic acids were bound to fresh silica-coated beads
under chaotropic conditions. Beads were washed 3 times and total
nucleic acids were eluted with 100 μl of elution buffer at 70 °C.
Molecular analysis
Hydrolysis probe assays were ora performed as described else-
where (van Eijk et al., 2011). In this method 10 μl qPCR reactions con-
tained 5 μl mastermix (FastStart Universal Probe Master, Roche
Diagnostics, Almere, The Netherlands), 1 μl of 10× primer and hydro-
lysis probe solutions and 2 μl DNA solution or sterile water. qPCR was
performed in a sealed 384 well plate in a qPCR instrument (CFX384,
Bio-Rad, Veenendaal, The Netherlands), with an initial denaturation
step of 10 min at 95 °C follow by 40 cycles of 15 s at 92 °C, 60 s at
60 °C and 10 s at 72 °C. In the experiments described below we
used 8 different assays, 7 for KRAS p.G12S, p.G12R, p.G12C, p.G12D,
p.G12A, p.G12V and p.G13D and one for the BRAF p.V600E variant.
Results
For molecular diagnostic analyses of hotspot mutations in KRAS and
BRAF on DNA isolated from small tissue cores or micro-dissected tissue
sections hydrolysis probe assays are often used. As described, DNA iso-
lation from FFPE tissue sections is possible with a fully automated sys-
tem in the routine laboratory (Hennig et al., 2010; Lehmann et al.,
2012). Since in our laboratory we isolate DNA in ~60% of the cases
from tissue cores, our ﬁrst assessment of the fully automated system
was to determine if DNA could be isolated from 0.3 mm tissue cores
taken from tumor ﬁelds of FFPE tissue blocks. We used 3 tissue cores
from 4 colon tumor/normal pairs, respectively for the classic and auto-
mated isolation methods as described in the Material and methods.
Final DNA was collected in 100 μl PK1 for the classic and 100 elution
buffer for the automated method. To check for the quality of the mate-
rial we performed the 8 hydrolysis probe assays with 2 μl of a 1:5 dilut-
ed stock of both eluates (Supplementary Table 1). All 64 data-points
were plotted in a scatterplot (Fig. 1A). The mean Cq of the “classic sam-
ples was 31.45 with a standard deviation of 1.55. The automatedmeth-
od had a mean Cq of 32.23 with a standard deviation of 1.96
demonstrating that Cq values obtained with the classic method are
in the same range as the Cq values obtained with the automated
method.
Micro-dissection
In our laboratory micro-dissection for tumor cell enrichment,
where 8 to 10 consecutive 10 μm sections are used as starting mate-
rial, is required in about 40% of the cases. Deparafﬁnized and stained
tumor containing ﬁelds are scraped off the different slides and
pooled. This process, at about 5 min per slide, adds up to approxi-
mately 1 h hands-on time.
We determined the threshold for the minimal input of the auto-
mated system by micro-dissecting in duplicate 1, 2 and 4 mm2 tissue
from deparafﬁnized and stained sections of a single 10 μm slide of a
colon and a lung specimen. DNA was extracted with the automated
method and eluted in a ﬁnal volume of 100 μl. Two μl of the eluate
was used in the KRAS and the BRAF hydrolysis probes assay. Mean
Cq values of 31.97±1.6, 31.45±1.5 and 29.93±1.3 were observed
for the 1, 2 and 4 mm2 tissue sections, respectively (Supplementary
Table 2). This demonstrates that as little as 1 mm2 micro dissected
Fig. 1. Scatter plots of hydrolysis probe assays Cq values over isolation type. Plot A
shows the Cq values obtained in DNA isolated from tissue cores in equal amounts of
DNA obtained with the classic and fully automated method with 8 different hydrolysis
probe assays for KRAS and BRAF. Plot B shows the Cq values obtained with equal
amounts of micro-dissected DNA in 8 different hydrolysis probe assays for KRAS and
BRAF. Plot C shows the Cq values obtained with a BRAF V600E Hydrolysis probes
assay on samples in two different, however comparable sets of samples tested in two
different time intervals in molecular diagnostics.
Fig. 2. Minimal input testing in the fully automated system. Wild type (grayscale) and
mutant (blue/black) ampliﬁcation curves of 1 mm2 (Circle), 2 mm2 (Triangle) and
4 mm2 (Cross) micro-dissected tissue parts originating from one single 10 μm slice of
a lung tumor harboring a KRAS c.34G>A p.G12S mutation.
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perform 50 qPCR reactions when using the automated extraction
method. In the colon cancer specimen a KRAS c.34G>A mutation
was clearly detectable in the 1, 2 and 4 mm2 micro-dissected tissue
sections. Remarkably the wild type allele tended to disappear in the
1 mm2 . This may possibly be explained by the loss of the wild type
allele or preferential ampliﬁcation of the mutant allele. (Fig. 2)
Subsequently, micro-dissection was performed on 14 different tis-
sue type specimen to enrich for tumor cells (Supplementary Table 3).
Like in routine diagnostics, eight sections per specimen were used for
the classic isolation with micro-dissection. These were compared to
two sections per specimen for micro-dissection with the automated
DNA isolation, thus 2×1 mm2 or more tissue was available for pro-
cessing. The classical isolates were eluted in PK1 varying from 12.5
to 75 μl depending on the amount of tumor material present(Supplementary Table 3). DNA isolates from the classical method
was diluted ﬁve times in sterile water prior to hydrolysis probe assays
while 2 μl of undiluted DNA obtained with the automated method
was always used. Eight assays detecting KRAS and BRAF hotspot muta-
tions were performed and Cq values were compared. The mean Cq for
the classical method was 32.10±2.9 and the automated method had
a mean Cq of 32.18±1.9. This indicated that although 4 times less tis-
sue was used for the automated method similar Cq's were obtained.
(Fig. 1B).
These results demonstrate that the automated method leads to at
least the same quality DNA and detection rates of mutations as com-
pared to the manual method while workload can be reduced and
quicker turnover (turnaround) times can be achieved. In the classical
protocol, micro dissecting ten replicates for each of 14 samples re-
quires up to 7 h hands-on time resulting in a total time including
DNA extraction of about 28 h before isolated DNA is available for
assay (Fig. 3). With the automated approach, micro dissecting only
two replicates for each of 14 samples requires up to 2 h hands-on
time resulting in a total time including DNA extraction of about only
6 h before isolated DNA is available for assay (Fig. 3).
To determine if the automated approach will have a positive effect
on both the hands-on time and turnover (turnaround) time we per-
formed the automated approach for four consecutive weeks. Al-
though the initial experiments demonstrated that micro-dissection
on two slides generally yielded sufﬁcient DNA for each test, we used
5 slides for micro-dissection in order to always guarantee sufﬁcient
DNA concentrations, accounting for very small tumors and/or much
degraded tissues. Using 5 slides for microdissection still reduces the
workload by half when compared to the classical method. To demon-
strate that the hydrolysis probe assays perform equally well with
DNA from both methods we compared the overall results from the
four week interval with a previous four week interval in which sam-
ples were isolated with the classical method. In the ﬁrst time interval,
DNA from 66 samples was isolated using the classical method and Cq
values for the KRAS and V600E assays were measured. In the second
time interval, the identical assay was performed on 70 independent
samples for which DNA was isolated using the fully automated meth-
od. In this way we compared a consecutive, representable series of
DNA from tumor tissue cores or microdissected tumors from different
tissue types (Supplementary Table 4). For the BRAF V600E assay the
results are shown in Fig. 1C. The mean Cq for the classical method
was 29.20±3.14 and 30.03±2.88 for the automated method. This in-
dicated that both methods compared well despite the different
amount of input DNA. (Fig. 1C). For the 7 KRAS assays comparable re-
sults were obtained (Supplementary Fig. 1).
Fig. 3. Laboratory implications for the fully automated method. Time evaluation of hands-on (red/black bar) and hands-off (gray bar) workﬂow from tissue section to ﬁrst molecular
results in the classical approach we start on Monday morning with the micro-dissection of 10 slides per sample request. One or two technicians work through this process until
about the middle of the afternoon. In contrast, with the automated approach, micro-dissection is performed on only ﬁve tissue sections, and the work is ﬁnished around noon. Con-
sequently, 50% of the hands-on time is saved. With the classical approach, on Monday afternoon the whole tissue sections or tissue cores are prepared and deparafﬁnized and an
overnight proteinase-K step is initiated. In the automated approach, the technician(s) ﬁnish the micro-dissection and start the DNA isolation around noon on Monday. At this point
they can walk away from the system. The entire extraction is ﬁnished on the same day. On the following day (Tuesday) hours of hands-on time can be saved because the technician
can immediately start with the qPCR processes instead of ﬁnishing the DNA isolation. This then results in the transfer of the results to the clinicians on Tuesday afternoon instead of
Wednesday morning. In the near future it might be even possible to start the qPCR reaction on Monday afternoon which makes it possible to have the results reported to the clinic
on Tuesday before noon. These results show that hands-on time, from tissue slide to ﬁrst molecular results, can be reduced by approximately 50%. In addition, it is likely that the
turnaround time can be further reduced to less than 24 h in the near future. To make this process transparent to a broader public the Department of Pathology made a video pre-
sentation of this process which can be viewed on http://www.scivee.tv/node/39348 (accessed February 24, 2012).
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We demonstrated that a fully automated DNA isolation method is
an excellent tool to obtain hands-on time reduction and lower turn-
over (turnaround) times in the daily practice of molecular tumor di-
agnostics. In an ideal situation the use of the fully automated
system allowed for molecular test results to be delivered to the clinic
about 24 h earlier than when the classical DNA isolation method was
used. However, it still remains to be seen if this gain in time can also
be achieved in daily practice. (Fig. 3)
The isolated DNA is suitable for mutation detection by high
throughput processes like routine hydrolysis probe assays. We demon-
strated that in small deparafﬁnized tissue cores DNA of at least the
same quality and quantity as with the classic method can be isolated.
In many cases where micro-dissection is required the automated sys-
tem provides signiﬁcant added value in the whole process. Although
deparafﬁnization and staining has already been performed before actu-
al micro-dissection takes place at least 50% hands-on time can be saved
by the fact that only 2 mm2 of material from a single 10 μm slide is ac-
tually required for good quality DNA. Further, the consumption of rare
and precious patient material is dramatically reduced. Thus, the auto-
mated extraction method also decreases the burden on a patient by all-
owing for the isolation of DNA from minimal biopsies or other very
small tissue fragments instead of larger tissue resections obtained by
invasive surgery. DNA isolated with the automated system using
nano-bead technology promises to be of sufﬁcient quality and
quantity for use in additional applications. It also potentially avoids
pre-ampliﬁcation protocols like whole genome ampliﬁcation which
again saves hands-on time, turnover (turnaround) time and costs.
The ﬁrst results of using DNA obtained from the fully automated
system in Sanger sequencing demonstrate that the overall quality of
the sequences is higher than in the classical process (assessed by in-
ternal quality score; data not shown). Consequently, extra DNA treat-
ment with whole genome ampliﬁcation procedures can probably
become obsolete for this application. Further validation of the auto-
mated extraction method should be performed for other types of as-
says such as microsatellite instability testing, clonality typing, MLPA,
Maldi-tof, SNP arrays and high throughput and deep sequencing.
We conclude that the fully-automated IVD extraction system de-
livers sufﬁcient and high quality DNA from precious FFPE tissue
cores and micro-dissected tissue material. It signiﬁcantly reduces
the amount of starting tissue and labor and turnaround time. The
automated and standardized extraction procedure can contribute toless operator-to-operator variability and reduces contamination risk
between samples. In addition, the ﬂexibility of the automated system
including the ability to process between 1 and 48 samples per run and
to select different protocols for both DNA and RNA while using the
same reagents and protocol makes it very amenable for current and
future high-throughput molecular laboratories.
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